Cart
sales@molnova.com
SARS-CoV-2 3CLpro-IN-20
CAS No. 878985-00-3
SARS-CoV-2 3CLpro-IN-20( —— )
Catalog No. M37021 CAS No. 878985-00-3
SARS-CoV-2 3CLpro-IN-20 is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.43 μM and potential antiviral activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | Get Quote |
|
| 10MG | 59 | Get Quote |
|
| 25MG | 90 | Get Quote |
|
| 50MG | 136 | Get Quote |
|
| 100MG | 196 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSARS-CoV-2 3CLpro-IN-20
-
NoteResearch use only, not for human use.
-
Brief DescriptionSARS-CoV-2 3CLpro-IN-20 is a covalent inhibitor of SARS-CoV-2 3CLpro with an IC50 of 0.43 μM and potential antiviral activity.
-
DescriptionSARS-CoV-2 3CLpro-IN-20 (Compound 5g) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 0.43 μM, Ki: ?0.33?μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorAntiviral | SARS-CoV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number878985-00-3
-
Formula Weight366.21
-
Molecular FormulaC19H12BrNO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 4.76 mg/mL (13.00 mM; Ultrasonic (<60°C)
-
SMILESC(N1C=2C(C(=O)C1=O)=CC(Br)=CC2)C3=CC4=C(C=C3)C=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bao HL, et al. Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors. Chem Biol Drug Des. 2023 Aug 10.
molnova catalog
related products
-
BIT225
BIT225 is a human immunodeficiency virus type 1 Vpu inhibitor with antiviral activity that inhibits HIV-1 replication in bone marrow dendritic cells and inhibits ion channels formed by HIV-1 Vpu.
-
Cyclosporin C
Cyclosporin C is a fungal metabolite against filamentous phytopathogenic fungi. Cyclosporin C has antifungal, antiviral, and immunosuppressant properties.
-
ITMN4077
ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
